Default: FASEB Journal

ISSN: 0892-6638

Journal Home

Journal Guideline

FASEB Journal Q1 Unclaimed

FASEB United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

FASEB Journal is a journal indexed in SJR in Molecular Biology and Medicine (miscellaneous) with an H index of 277. It has an SJR impact factor of 1,709 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,709.

FASEB Journal focuses its scope in these topics and keywords: human, receptor, protein, cell, expression, cells, induced, signaling, dna, role, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

FASEB Journal

1,709

SJR Impact factor

277

H Index

1158

Total Docs (Last Year)

2191

Total Docs (3 years)

64840

Total Refs

9923

Total Cites (3 years)

2153

Citable Docs (3 years)

4,34

Cites/Doc (2 years)

55,99

Ref/Doc

Aims and Scope


human, receptor, protein, cell, expression, cells, induced, signaling, dna, role, vivo, implications, response, peptide, factor, cd, therapeutic, heart, imaging, increases, intestinal, metabolic, muscle, system, terminus, tissue,



Best articles by citations

Senescence of human skeletal muscle impairs the local inflammatory cytokine response to acute eccentric exercise

View more

Factors limiting autogene-based cytoplasmic expression systems

View more

Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia

View more

A maternal blood-borne factor promotes survival of the developing thalamus

View more

Endothelial cell modulation of bone marrow stromal cell osteogenic potential

View more

Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells

View more

The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c- Jun/AP-1 signaling

View more

Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics

View more

HO-1 induction restores c-AMP-dependent lung epithelial fluid transport following severe hemorrhage in rats

View more

Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease

View more

Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the a-glucosidase inhibitor acarbose

View more

Conversion of a scorpion toxin agonist into an antagonist highlights an acidic residue involved in voltage sensor trapping during activation of neuronal Na

View more
SHOW MORE ARTICLES

Functional genomic analysis of the ADP-ribosylation factor family of GTPases: phylogeny among diverse eukaryotes and function in

View more

Just lip prints? No: there could be something else

View more

Inhibition of host connective tissue growth factor expression: a novel

View more

Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure

View more

Molecular basis of the mammalian potency of the scorpion a-like toxin, BmK M1

View more

Peroxynitrite induces senescence and apoptosis of red blood cells through the activation of aspartyl and cysteinyl proteases

View more

Isoprostanes: markers and mediators of oxidative stress

View more

Ref-1/Ape is critical for formation of the hypoxia-inducible transcriptional complex on the hypoxic response element of the rat pulmonary artery endothelial cell VEGF gene

View more

The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67

View more

The wild-type Ras: road ahead

View more

Apoptotic adaptations from exercise training in skeletal and cardiac muscles

View more

Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS-responses

View more

Comments

No comments ... Be the first to comment!

FAQS